Lesson plan
Algifen
Algifen is trademark of compositional analgesic drug based on mixture of metamizole, pitofenone and fenpiverinium. It was produced by Zentiva in tablet-form, it was marketed in Central and Eastern Europe. Similar drug combinations are now marketed by Teva under the name Algifen Neo (in the form of peroral drops). Composition (per 1 ml): metamizole 500 mg, pitofenone 5 mg. It is frequently used during urinary infection to relieve pain.
Article summary
Algifen is trademark of compositional analgesic drug based on mixture of metamizole, pitofenone and fenpiverinium. It was produced by Zentiva in tablet-form, it was marketed in Central and Eastern Europe. Similar drug combinations are now marketed by Teva under the name Algifen Neo (in the form of peroral drops). Composition (per 1 ml): metamizole 500 mg, pitofenone 5 mg. It is frequently used during urinary infection to relieve pain.
Key claims
No claims recorded.
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.